Correlation Between Sarepta Therapeutics and Annovis Bio

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and Annovis Bio, you can compare the effects of market volatilities on Sarepta Therapeutics and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Annovis Bio.

Diversification Opportunities for Sarepta Therapeutics and Annovis Bio

0.2

Correlation Coefficient

Sarepta Therapeutics  Annovis Bio

Modest diversification

The 3 months correlation between Sarepta and Annovis is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Annovis Bio go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Annovis Bio

Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 1.7 times less return on investment than Annovis Bio. But when comparing it to its historical volatility, Sarepta Therapeutics is 3.22 times less risky than Annovis Bio. It trades about 0.02 of its potential returns per unit of risk. Annovis Bio is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,302  in Annovis Bio on October 5, 2024 and sell it today you would lose (791.00) from holding Annovis Bio or give up 60.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sarepta Therapeutics  vs.  Annovis Bio

Sarepta Therapeutics

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sarepta Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Sarepta Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Annovis Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Sarepta Therapeutics and Annovis Bio

The main advantage of trading using opposite Sarepta Therapeutics and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.

The idea behind Sarepta Therapeutics and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.